CRP and myocardial infarction: CRP is an acute-phase reactant that has been shown in many cohort studies to be a reliable measure of underlying systemic inflammation and a predictor of future myocardial infarction and stroke (Danesh et al. 2004; Emerging Risk Factors Collaboration et al. 2010).